CRTD (Creatd Inc.) Sells Remaining 80% of Fly Flyte to NYSE-Listed VTAK (Catheter Precision Inc.), Securing Significant Cash and Equity Position

NEW YORK, March 10, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Creatd, Inc. (OTCQB: CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. (“Flyte”), to Catheter Precision, Inc. (NYSE American: VTAK).